RxSight (RXST) Change in Inventory (2020 - 2026)

RxSight (RXST) has reported Change in Inventory for 7 consecutive years, with $3.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Inventory rose 24.33% year-over-year to $3.4 million; the trailing twelve-month figure through Jun 2026 stood at $13.9 million (up 95.79% YoY), and the FY2025 full-year result was $11.5 million, up 129.96% from the prior year.
• Change in Inventory steadied at $3.4 million in Q2 2026 per RXST's latest filing, from $3.4 million in the prior quarter.
• Across five years, Change in Inventory topped out at $4.0 million in Q3 2022 and bottomed at -$1.4 million in Q4 2023.
• Historically, Change in Inventory has averaged $1.9 million across 5 years, with a median of $2.0 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Change in Inventory tumbled 566.01% in 2023, then surged 782.91% in 2024.
• Over 5 years, Change in Inventory stood at -$203000.0 in 2022, then sank by 566.01% to -$1.4 million in 2023, then soared by 130.18% to $408000.0 in 2024, then soared by 690.44% to $3.2 million in 2025, then grew by 4.28% to $3.4 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered $3.4 million, $3.4 million, and $3.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.